Zydus Lifesciences informs about press release

11 Nov 2025 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated November 11, 2025, titled ‘Zydus receives approval from China’s NMPA for Venlafaxine Extended-Release Capsules, 75 mg and 150 mg’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

884.85 8.75 (1.00%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×